SCHEMBL27666286

SCHEMBL27666286

[c]1nc2c(N3CCN(CCc4ccccc4)CC3)cccc2s1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 1/20 0.54
KMT2A Q03164 1/20 0.54
ADRA1D P25100 2/20 0.51
ADRA1A P35348 2/20 0.51
ADRA1B P35368 2/20 0.51
CYP2C9 P11712 1/20 0.51
HTR1A P08908 1/20 0.50
DRD2 P14416 1/20 0.50
SIGMAR1 Q99720 1/20 0.45
MAPT P10636 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27644453 0.88 SIGMAR1 (0.47) MEN1ALDH1A1KMT2AADRA1DADRA1A
SCHEMBL28761481 0.85 HRH3 (0.43) MEN1ALDH1A1KMT2AADRA1DADRA1A
SCHEMBL27644980 0.81 CTSS (0.42) DRD2
SCHEMBL27665936 0.79 HRH3 (0.46) ALDH1A1ADRA1AADRA1BDRD2SIGMAR1
SCHEMBL27666169 0.78 HRH3 (0.47) ADRA1AADRA1BHTR1ADRD2SIGMAR1
SCHEMBL5013459 0.78 MEN1 (0.52) MEN1ALDH1A1KMT2AADRA1DADRA1A
SCHEMBL27645120 0.78 HRH3 (0.47) ADRA1AADRA1BHTR1ADRD2SIGMAR1
SCHEMBL27645136 0.78 HRH3 (0.47) ADRA1AADRA1BHTR1ADRD2SIGMAR1
SCHEMBL28758331 0.77 DRD4 (0.45) MEN1ALDH1A1KMT2ADRD2SIGMAR1
SCHEMBL27644481 0.77 ALDH1A1 (0.52) MEN1ALDH1A1KMT2AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed